Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VCAM1 | P19320 | 10/20 | 0.44 |
| ▸ | CACNA1A | O00555 | 1/20 | 0.38 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.38 |
| ▸ | CACNB1 | Q02641 | 1/20 | 0.38 |
| ▸ | GLRA3 | O75311 | 1/20 | 0.36 |
| ▸ | GLRB | P48167 | 1/20 | 0.36 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.35 |
| ▸ | GSR | P00390 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | APP | P05067 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3683439 | 0.85 | VCAM1 (0.39) | VCAM1CACNA1ACACNA2D1CACNB1GLRA3 | |
| SCHEMBL28961380 | 0.83 | CACNA1A (0.45) | VCAM1CACNA1ACACNA2D1CACNB1KDM4E | |
| SCHEMBL2474153 | 0.82 | CYP1A2 (0.40) | VCAM1CACNA1ACACNA2D1CACNB1GLRA3 | |
| SCHEMBL7689933 | 0.81 | VCAM1 (0.41) | VCAM1CACNA1ACACNA2D1CACNB1GLRA3 | |
| SCHEMBL27390100 | 0.79 | ESR1 (0.43) | SMN1; SMN2 | |
| SCHEMBL28219118 | 0.79 | ESR1 (0.43) | SMN1; SMN2 | |
| SCHEMBL9705163 | 0.79 | ESR1 (0.43) | — | |
| SCHEMBL28860107 | 0.79 | ESR1 (0.43) | SMN1; SMN2 | |
| SCHEMBL2354392 | 0.78 | CYP1A2 (0.36) | VCAM1CACNA1ACACNA2D1CACNB1GLRA3 | |
| SCHEMBL11706491 | 0.78 | VCAM1 (0.44) | VCAM1GSRLMNARECQLKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1846367-B1 | ALIPHATIC, CYCLOALIPHATIC OR (CYCLO)ALIPHATIC DIISOCYANATES THAT ARE STABLE IN STORAGE | EVONIK DEGUSSA GMBH (DE) | 2016-03-09 | — | — | EP | claimed |
| US-20100168329-A1 | ALIPHATIC, CYCLOALIPHATIC OR (CYCLO)ALIPHATIC DIISOCYANATES THAT ARE STABLE IN STORAGE | DEGUSSA GMBH (DE) | 2010-07-01 | — | — | US | claimed |
| US-20260103594-A1 | THERMOPLASTIC MOULDING COMPOSITIONS HAVING AN IMPROVED COLOUR STABILITY-3 | BASF SE (DE) | 2026-04-16 | — | — | US | disclosed |
| US-20260103596-A1 | THERMOPLASTIC MOULDING COMPOSITIONS HAVING AN IMPROVED COLOUR STABILITY-1 | BASF SE (DE) | 2026-04-16 | — | — | US | disclosed |
| EP-4536741-B1 | RECYCLING METHOD FOR PRODUCING A POLYAMIDE COMPOUND | BASF SE (DE) | 2026-01-21 | — | — | EP | disclosed |
| US-20250320346-A1 | RECYCLING METHOD FOR PRODUCING A POLYAMIDE COMPOUND | BASF SE (DE) | 2025-10-16 | — | — | US | disclosed |
| WO-2025049564-A1 | POLYAMIDE MOLDING COMPOSITIONS WITH IMPROVED HEAT-AGING RESISTANCE | BASF SE (DE) | 2025-03-06 | — | — | WO | disclosed |
| EP-4255964-B1 | AQUEOUS LACTAM SOLUTION OF LIGNIN | BASF SE (DE) | 2024-11-13 | — | — | EP | disclosed |
| US-20240279464-A1 | THERMOPLASTIC MOULDING COMPOSITION RETAINING HIGH GLOSS | BASF SE (DE) | 2024-08-22 | — | — | US | disclosed |
| US-20240209184-A1 | ALIPHATIC COPOLYAMIDE COMPOSITION | BASF SE (DE) | 2024-06-27 | — | — | US | disclosed |
| EP-4121483-B1 | PLASTICIZED POLYAMIDE MOLDING COMPOSITIONS | BASF SE (DE) | 2024-05-08 | — | — | EP | disclosed |
| US-20120029122-A1 | FLAME RETARDANT MOLDING COMPOSITIONS | BASF SE (DE) | 2012-02-02 | — | — | US | disclosed |
| US-20110294910-A1 | EXPANDABLE PELLETIZED POLYAMIDE MATERIAL | BASF SE (DE) | 2011-12-01 | — | — | US | disclosed |
| US-20110224347-A1 | POLYAMIDES THAT RESIST HEAT-AGING | BASF SE (DE) | 2011-09-15 | — | — | US | disclosed |
| US-7989537-B2 | Reduced formaldehyde emissions; safe for food and drink containers, toys, packaging, construction materials | BASF AKTIENGESELLSCHAFT (DE) | 2011-08-02 | — | — | US | disclosed |
| US-20080085968-A1 | Moulding Compound Comprising Polyoxymethylene And Zeolite | BASF AKTIENGESELLSCHAFT (DE) | 2008-04-10 | — | — | US | disclosed |
| US-20030175492-A1 | Antistatic polyoxymethylene molding compounds | BASF AKTIENGESELLSCHAFT (DE) | 2003-09-18 | — | — | US | disclosed |
| US-20010034415-A1 | Impact-modified thermoplastic polymer mixtures based on SO2 copolymers having an aliphatic main chain | BASF AKTIENGESELLSCHAFT (DE) | 2001-10-25 | — | — | US | disclosed |
| US-5808138-A | BUBBLING OR ADDING SOLID CARBON DIOXIDE | BASF AKTIENGESELLSCHAFT (DE) | 1998-09-15 | — | — | US | disclosed |
| US-5728317-A | POLYISOCYANURATES FROM POLYISOCYANATES WITH STABILIZERS | BASF AKTIENGESELLSCHAFT (DE) | 1998-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103594-A1 | THERMOPLASTIC MOULDING COMPOSITIONS HAVING AN IMPROVED COLOUR STABILITY-3 | SMC3, ASIC3, PUF60 | VCAM1 1911/4885CACNA1A 37/4885CACNA2D1 646/4885 |
| US-20100168329-A1 | ALIPHATIC, CYCLOALIPHATIC OR (CYCLO)ALIPHATIC DIISOCYANATES THAT ARE STABLE IN STORAGE | DDT, AADAC, SCD | VCAM1 3917/4885CACNA1A 4393/4885CACNA2D1 4298/4885 |
| US-20260103596-A1 | THERMOPLASTIC MOULDING COMPOSITIONS HAVING AN IMPROVED COLOUR STABILITY-1 | PUF60, PHPT1, P4HA1 | VCAM1 3353/4885CACNA1A 117/4885CACNA2D1 346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.